Granules India Limited (GRANULES)
₹592.5
INR-4.35(-0.73%)
As of December 26, 2024 9:59:00 AMAbout Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
2.99
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
15.60
+-4.8% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
13397.07 CrINR
Total market value of the company's outstanding shares
Employees
4057
Total number of full-time employees worldwide
CEO
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
Chief Executive Officer of the company